CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Board Of Directors

Michael J. Mona, Jr.

CEO, President & Founder

Mr. Mona is the founder of CV Sciences and possesses over 30 years of senior management experience in a range of industries including real estate/construction, industrial farming, chemical processing and consumer products. Mr. Mona is a recognized industry leader in hemp farming operations and chemical extraction and has established a global supply chain of hemp-derived products.

Michael J. Mona, III

COO, SVP & Cofounder

Mr. Mona III cofounded CV Sciences and has been instrumental in developing the worldwide supply chain for hemp products. Mr. Mona’s expertise in hemp farming, processing, testing and product development has directly led to the Company’s successful consumer products division. Mr. Mona III graduated from the University of San Diego in Business Administration.

Gary Sligar

Director of CV Sciences

Mr. Gary R. Sligar served as Managing Principal, President at Trecap Partners, LLC. Mr. Sligar joined Equitable Real Estate in 1986 with responsibility for New York Region asset management operations. Mr. Sligar was the Executive Vice President responsible for the New York office asset management operations for Equitable Real Estate from 1986 to 1989. Mr. Sligar’s career spans 35 years in the commercial real estate industry including appraisal, commercial mortgage, property/asset management, leasing, construction and development. He serves as a Director of the Real Estate Board of New York, Building Owners and Managers Association, and NAIOP. He has served as a Director of CV Sciences, Inc. since June 2, 2016. He received his Bachelor Degree from Tulsa University and completed his graduate study at the University of Houston.

James McNulty

Director of CV Sciences

Mr. James A. McNulty, CPA, has served as a Director of CV Sciences, Inc. since January 1, 2016. James A. McNulty, CPA is CEO of MYMD Pharmaceuticals, Inc. (development stage pharmaceutical company), and is Chief Financial Officer for Hopkins Capital Group, an affiliation of limited liability companies which engage in venture activities primarily in development of pharmaceuticals. He serves as Chief Financial Officer of Repurposed Therapeutics, Inc. and Secretary/Chief Compliance Officer for Hedgepath Pharmaceuticals, Inc. (OTC: HPPI). Mr. McNulty was Chief Financial Officer of Biodelivery Sciences International, Inc. (NASDAQ: BDSI) from 2000 until his retirement from BDSI in December 2014.

STEPHEN M. SCHMITZ, MD, MPH

Director of CV Sciences

Stephen M. Schmitz, MD, MPH, is a board certified physician with nearly 20 years of experience in drug and dietary supplement safety. After a family medicine residency, he established a hospital-based wellness center in Connecticut, and later worked in clinical occupational medicine. A long-time believer in the safety and effectiveness dietary supplements, he co-founded Supplement Safety Solutions, which offers consulting services to supplement companies to help them stay compliant with regulations and assure the safety of their products. In 2017, he was honored to become a member of the board of directors of CV Sciences, where he hopes to bring his medical knowledge to help expand the use of the products. He is a passionate believer in the potential of CBD to optimize preventive health and to help improve with numerous medical conditions. He lives on the east coast with his wife, and is the proud father of a budding artist and accountant. In his spare time, he enjoys mountain biking, gardening and performing standup comedy.